[PDF][PDF] Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale: Policy brief
World Health Organization - 2016 - apps.who.int
BACkGROunD Primaquine is currently the only medicine for treating relapses of
Plasmodium vivax and P. ovale malaria, due to its specific activity against malaria …
Plasmodium vivax and P. ovale malaria, due to its specific activity against malaria …
Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria
K Baird - Pathogens and global health, 2015 - Taylor & Francis
Most of the tens of millions of clinical attacks caused by Plasmodium vivax each year likely
originate from dormant liver forms called hypnozoites. We do not systematically attack that …
originate from dormant liver forms called hypnozoites. We do not systematically attack that …
Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: divergent policies and practices in malaria endemic countries
Primaquine is the only available antimalarial drug that kills dormant liver stages of
Plasmodium vivax and Plasmodium ovale malarias and therefore prevents their relapse …
Plasmodium vivax and Plasmodium ovale malarias and therefore prevents their relapse …
G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests
GJ Domingo, AW Satyagraha, A Anvikar, K Baird… - 2013 - Springer
Malaria elimination will be possible only with serious attempts to address asymptomatic
infection and chronic infection by both Plasmodium falciparum and Plasmodium vivax …
infection and chronic infection by both Plasmodium falciparum and Plasmodium vivax …
A review of the current status of G6PD deficiency testing to guide radical cure treatment for vivax malaria
Plasmodium vivax malaria continues to cause a significant burden of disease in the Asia-
Pacific, the Horn of Africa, and the Americas. In addition to schizontocidal treatment, the 8 …
Pacific, the Horn of Africa, and the Americas. In addition to schizontocidal treatment, the 8 …
Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency
S Kheng, S Muth, WRJ Taylor, N Tops, K Kosal… - BMC medicine, 2015 - Springer
Background Primaquine is used to prevent Plasmodium vivax relapse; however, it is not
implemented in many malaria-endemic countries, including Cambodia, for fear of …
implemented in many malaria-endemic countries, including Cambodia, for fear of …
Single low dose primaquine (0.25 mg/kg) does not cause clinically significant haemolysis in G6PD deficient subjects
G Bancone, N Chowwiwat, R Somsakchaicharoen… - PloS one, 2016 - journals.plos.org
Background Primaquine is the only drug consistently effective against mature gametocytes
of Plasmodium falciparum. The transmission blocking dose of primaquine previously …
of Plasmodium falciparum. The transmission blocking dose of primaquine previously …
Mass primaquine treatment to eliminate vivax malaria: lessons from the past
A Kondrashin, AM Baranova, EA Ashley, J Recht… - Malaria journal, 2014 - Springer
Recent successes in malaria control have put malaria eradication back on the public health
agenda. A significant obstacle to malaria elimination in Asia is the large burden of …
agenda. A significant obstacle to malaria elimination in Asia is the large burden of …
G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
Background The incidence of malaria in the Americas has decreased markedly in recent
years. Honduras and the other countries of Mesoamerica and the island of Hispaniola have …
years. Honduras and the other countries of Mesoamerica and the island of Hispaniola have …
相关搜索
- use of primaquine g6pd deficiency
- radical cure g6pd deficiency
- radical cure safe use
- policy brief g6pd deficiency
- policy brief safe use
- radical cure policy brief
- g6pd testing elimination of malaria
- use of primaquine malaria treatment
- dehydrogenase deficiency plasmodium vivax
- use of primaquine prevalence and distribution
- malaria treatment g6pd deficiency
- prevalence and distribution g6pd deficiency
- weekly primaquine plasmodium vivax
- weekly primaquine dehydrogenase deficiency
- g6pd testing support of treatment
- use of primaquine divergent policies